Lenaic Nathanael Teyssedou insider trades

Open-market stock purchases and sales by Lenaic Nathanael Teyssedou, PRINCIPAL ACCOUNTING OFFICER at Addex Therapeutics Ltd, from SEC Form 4 filings since Sep 2, 2026.

Recent trades

DateStockTradeValue
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdSold (not open market)—
Sep 2, 2026ADXN Addex Therapeutics LtdBought (not open market)—

Companies traded

  • ADXN Addex Therapeutics Ltd: other filings, last Sep 2, 2026

Get free alerts when Lenaic Nathanael Teyssedou files a new trade →